Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03010004 PGD2 cPLA2i 1.0 BCD110605C28 0.072 pmol/ml medium
LMFA03010004 PGD2 cPLA2i 1.0 BCD110605C30 0.108 pmol/ml medium
LMFA03010004 PGD2 cPLA2i 1.0 BCD110605C29 0.164 pmol/ml medium
LMFA03010004 PGD2 cPLA2i 20.0 BCD110605C64 0.097 pmol/ml medium
LMFA03010004 PGD2 cPLA2i 20.0 BCD110605C66 0.147 pmol/ml medium
LMFA03010004 PGD2 cPLA2i 20.0 BCD110605C65 0.065 pmol/ml medium
LMFA03010004 PGD2 PLDi 1.0 BCD110605C16 0.106 pmol/ml medium
LMFA03010004 PGD2 PLDi 1.0 BCD110605C17 0.121 pmol/ml medium
LMFA03010004 PGD2 PLDi 1.0 BCD110605C18 0.118 pmol/ml medium
LMFA03010004 PGD2 PLDi 20.0 BCD110605C54 0.16 pmol/ml medium
LMFA03010004 PGD2 PLDi 20.0 BCD110605C52 0.193 pmol/ml medium
LMFA03010004 PGD2 PLDi 20.0 BCD110605C53 0.188 pmol/ml medium
LMFA03010004 PGD2 KDO+cPLA2i 1.0 BCD110605C32 0.469 pmol/ml medium
LMFA03010004 PGD2 KDO+cPLA2i 1.0 BCD110605C31 0.539 pmol/ml medium
LMFA03010004 PGD2 KDO+cPLA2i 1.0 BCD110605C33 0.546 pmol/ml medium
LMFA03010004 PGD2 KDO+cPLA2i 20.0 BCD110605C68 0.402 pmol/ml medium
LMFA03010004 PGD2 KDO+cPLA2i 20.0 BCD110605C69 0.569 pmol/ml medium
LMFA03010004 PGD2 KDO+cPLA2i 20.0 BCD110605C67 0.587 pmol/ml medium
LMFA03010004 PGD2 KDO+PLDi 1.0 BCD110605C19 0.431 pmol/ml medium
LMFA03010004 PGD2 KDO+PLDi 1.0 BCD110605C20 0.4 pmol/ml medium
LMFA03010004 PGD2 KDO+PLDi 1.0 BCD110605C21 0.469 pmol/ml medium
LMFA03010004 PGD2 KDO+PLDi 20.0 BCD110605C56 0.89 pmol/ml medium
LMFA03010004 PGD2 KDO+PLDi 20.0 BCD110605C57 0.873 pmol/ml medium
LMFA03010004 PGD2 KDO+PLDi 20.0 BCD110605C55 0.887 pmol/ml medium
LMFA03010004 PGD2 KDO+ATP+cPLA2i 1.0 BCD110605C37 0.859 pmol/ml medium
LMFA03010004 PGD2 KDO+ATP+cPLA2i 1.0 BCD110605C38 0.87 pmol/ml medium
LMFA03010004 PGD2 KDO+ATP+cPLA2i 1.0 BCD110605C39 0.879 pmol/ml medium
LMFA03010004 PGD2 KDO+ATP+cPLA2i 20.0 BCD110605C74 1.01 pmol/ml medium
LMFA03010004 PGD2 KDO+ATP+cPLA2i 20.0 BCD110605C75 1.05 pmol/ml medium
LMFA03010004 PGD2 KDO+ATP+cPLA2i 20.0 BCD110605C73 1.05 pmol/ml medium
LMFA03010004 PGD2 KDO+ATP+PLDi 1.0 BCD110605C25 1.19 pmol/ml medium
LMFA03010004 PGD2 KDO+ATP+PLDi 1.0 BCD110605C27 0.83 pmol/ml medium
LMFA03010004 PGD2 KDO+ATP+PLDi 1.0 BCD110605C26 1.07 pmol/ml medium
LMFA03010004 PGD2 KDO+ATP+PLDi 20.0 BCD110605C61 2.84 pmol/ml medium
LMFA03010004 PGD2 KDO+ATP+PLDi 20.0 BCD110605C62 2.86 pmol/ml medium
LMFA03010004 PGD2 KDO+ATP+PLDi 20.0 BCD110605C63 2.64 pmol/ml medium
LMFA03010004 PGD2 KDO + ATP 1.0 BCD110605C15 1.25 pmol/ml medium
LMFA03010004 PGD2 KDO + ATP 1.0 BCD110605C14 1.48 pmol/ml medium
LMFA03010004 PGD2 KDO + ATP 1.0 BCD110605C13 0.122 pmol/ml medium
LMFA03010004 PGD2 KDO + ATP 20.0 BCD110605C49 3.26 pmol/ml medium
LMFA03010004 PGD2 KDO + ATP 20.0 BCD110605C50 3.66 pmol/ml medium
LMFA03010004 PGD2 KDO + ATP 20.0 BCD110605C51 3.45 pmol/ml medium
LMFA03010004 PGD2 KDO 1.0 BCD110605C08 0.628 pmol/ml medium
LMFA03010004 PGD2 KDO 1.0 BCD110605C07 0.617 pmol/ml medium
LMFA03010004 PGD2 KDO 1.0 BCD110605C09 0.754 pmol/ml medium
LMFA03010004 PGD2 KDO 20.0 BCD110605C45 0.869 pmol/ml medium
LMFA03010004 PGD2 KDO 20.0 BCD110605C44 0.907 pmol/ml medium
LMFA03010004 PGD2 KDO 20.0 BCD110605C43 0.906 pmol/ml medium
LMFA03010004 PGD2 C 0.0 BCD110605C03 0.099 pmol/ml medium
LMFA03010004 PGD2 C 0.0 BCD110605C01 0.074 pmol/ml medium